A series of ruthenium(II) arene derivatives (arene = cymene (cym), hexamethylbenzene (hmb)) containing avobenzone (1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione, AVBH) and PTA (1,3,5-triaza-7-phosphaadamantane) or PTA-Me (N-methyl-1,3,5-triaza-7-phosphaadamantane cation) have been synthesized and fully characterized. Three types of complexes have been obtained: i.e., neutral [Ru(arene)(AVB)Cl] (1, arene = cym; 2, arene = hmb), monocationic [Ru(arene)(AVB)(PTA)][SO3CF3] (3, arene = cym; 4, arene = hmb), and dicationic [Ru(arene)(AVB)(PTA-Me)][SO3CF3][BF4] (5, arene = cym; 6, arene = hmb). The solid-state structures of 1 and 2 were determined by single-crystal X-ray diffraction. The cytotoxicity of the complexes has been evaluated in vitro against human ovarian carcinoma cells, A2780 and A2780cisR, as well as against nontumorous Human Embryonic Kidney (HEK293) cells. The ionic complexes with hydrophilic PTA and PTA-Me ligands in 3–6 are considerably more active than the neutral complexes 1 and 2.

From Sunscreen to Anticancer Agent: Ruthenium(II) Arene Avobenzone Complexes Display Potent Anticancer Activity

PETTINARI, Riccardo;MARCHETTI, Fabio;PETRINI, Agnese;PETTINARI, Claudio;LUPIDI, Giulio;
2016-01-01

Abstract

A series of ruthenium(II) arene derivatives (arene = cymene (cym), hexamethylbenzene (hmb)) containing avobenzone (1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione, AVBH) and PTA (1,3,5-triaza-7-phosphaadamantane) or PTA-Me (N-methyl-1,3,5-triaza-7-phosphaadamantane cation) have been synthesized and fully characterized. Three types of complexes have been obtained: i.e., neutral [Ru(arene)(AVB)Cl] (1, arene = cym; 2, arene = hmb), monocationic [Ru(arene)(AVB)(PTA)][SO3CF3] (3, arene = cym; 4, arene = hmb), and dicationic [Ru(arene)(AVB)(PTA-Me)][SO3CF3][BF4] (5, arene = cym; 6, arene = hmb). The solid-state structures of 1 and 2 were determined by single-crystal X-ray diffraction. The cytotoxicity of the complexes has been evaluated in vitro against human ovarian carcinoma cells, A2780 and A2780cisR, as well as against nontumorous Human Embryonic Kidney (HEK293) cells. The ionic complexes with hydrophilic PTA and PTA-Me ligands in 3–6 are considerably more active than the neutral complexes 1 and 2.
2016
262
File in questo prodotto:
File Dimensione Formato  
108 Organometallics 2016, 35, 3734−3742.pdf

solo gestori di archivio

Descrizione: Articolo principale
Tipologia: Versione Editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 812.68 kB
Formato Adobe PDF
812.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11581/393815
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 38
social impact